Several investigations confirmed the benefit of supplementation of caffeine or L-cysteine in clinical susceptibility, presentation, and prognosis for COVID-19 patients, possibly through blocking the virus from penetrating host cells or decreasing viral replication by preventing the action of 3-chymotrypsin-like proteases (46, 47). Here, CTRL is linked to COVID-19.